Cannabics files patent for personalized cannabimetic compositions modeling, production

Cannabics Pharmaceuticals Inc., a world leader in personalized cannabinoid medicine focused on cancer and its side effec...

December 27, 2018 | Thursday | News
I-Mab gets UDFDA IND nod for exclusive monoclonal antibody TJM2

I-Mab Biopharma (I-Mab), a China-based clinical-stage biopharmaceutical company exclusively focused on the developm...

December 24, 2018 | Monday | Company results
Roivant Sciences, Daiichi Sankyo enter into broad pipeline partnership

Roivant Sciences has announced that it has entered into collaboration with Daiichi Sankyo Company, Limited (hereafter, D...

December 20, 2018 | Thursday | News
Lexicon Pharma announces positive topline clinical data for LX9211

Biopharma company Lexicon Pharmaceuticals, Inc. has announced positive topline results from its Phase 1a study of LX9211...

December 19, 2018 | Wednesday | News
Bridge Bio signs $40M license agreement with Daewoong Pharma

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, South Korea, has signed a licen...

December 19, 2018 | Wednesday | News
FibroGen's roxadustat OK'd in China

Singapore – China's National Medical Products Administration approves FibroGen's roxadustat, a hypoxia-i...

December 18, 2018 | Tuesday | News
Avacta, LG Chem Life Sciences to develop novel drugs for cancer, inflammation

UK-based Avacta Group plc , the developer of Affimer biotherapeutics and reagents and Korea's LG Chem Life Science...

December 13, 2018 | Thursday | News
Innovent declares positive result of IBI305, biosimilar to Avastin

Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commerci...

December 13, 2018 | Thursday | News
APLIDIN gets world-first approval for Multiple Myeloma

Multiple myeloma patients from Australia will have world-first access to a new first-in-class drug developed to treat th...

December 11, 2018 | Tuesday | News
TauRx's LMTXs gets FDA Orphan-drug Designation

TauRx, a leader in neurodegenerative disease research, announced that the US Food and Drug Administration (FDA) has gran...

December 10, 2018 | Monday | News
Diamyd Medical raises SEK 58.4 million through redemption of warrants

Diamyd Medical is dedicated to finding a cure for diabetes and other serious inflammatory diseases through pharmaceutica...

December 6, 2018 | Thursday | News
EC Approves Takeda’s ALUNBRIG for ALK+ Non-Small Cell Lung Cancer

Takeda Pharmaceutical Company Limited announced that the European Commission (EC) granted marketing authorization for AL...

November 28, 2018 | Wednesday | News
HitGen, Biogen initiate drug discovery collaboration

HitGen Ltd has announced that the company has entered into a drug discovery research collaboration with Biogen to identi...

November 22, 2018 | Thursday | News
World’s first migraine-specific prevention treatment available in Singapore

Singapore – Novartis announced that the Health Sciences Authority (HSA) has approved Aimovig (erenumab) ...

November 22, 2018 | Thursday | News
OBI Pharma granted FDA ODD for OBI-888

OBI Pharma, Inc., a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) h...

November 21, 2018 | Wednesday | News
Exscientia acquires Kinetic Discovery to build 'full stack' AI-driven drug discovery capabilities

Singapore - Exscientia, the company leading the use of Artificial Intelligence (AI) in drug discovery, announces that is...

November 15, 2018 | Thursday | News
MEI Pharma, KHK to develop and commercialize ME-401

MEI Pharma, Inc. and Kyowa Hakko Kirin Co., Ltd. (KHK), have announced the execution of a license agreement granting KHK...

November 5, 2018 | Monday | News
FDA OKs J&J's Invokana for heart conditions

Singapore –  The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the U.S. Food and D...

October 31, 2018 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls